YU42163B - Process for obtaining derivatives 3-(1h-tetrazole-5-yl)-4h-pyrido(1,2-a)pyrimidin-4-ones - Google Patents

Process for obtaining derivatives 3-(1h-tetrazole-5-yl)-4h-pyrido(1,2-a)pyrimidin-4-ones

Info

Publication number
YU42163B
YU42163B YU1236/78A YU123678A YU42163B YU 42163 B YU42163 B YU 42163B YU 1236/78 A YU1236/78 A YU 1236/78A YU 123678 A YU123678 A YU 123678A YU 42163 B YU42163 B YU 42163B
Authority
YU
Yugoslavia
Prior art keywords
pyrido
tetrazole
pyrimidin
ones
obtaining derivatives
Prior art date
Application number
YU1236/78A
Other languages
English (en)
Other versions
YU123678A (en
Inventor
P F Juby
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of YU123678A publication Critical patent/YU123678A/xx
Publication of YU42163B publication Critical patent/YU42163B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40—Acylated substituent nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
YU1236/78A 1977-05-25 1978-05-24 Process for obtaining derivatives 3-(1h-tetrazole-5-yl)-4h-pyrido(1,2-a)pyrimidin-4-ones YU42163B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/800,264 US4122274A (en) 1977-05-25 1977-05-25 3-Tetrazolo-5,6,7,8-substituted-pyrido[1,2-a]pyrimidin-4-ones

Publications (2)

Publication Number Publication Date
YU123678A YU123678A (en) 1983-02-28
YU42163B true YU42163B (en) 1988-06-30

Family

ID=25177928

Family Applications (2)

Application Number Title Priority Date Filing Date
YU1236/78A YU42163B (en) 1977-05-25 1978-05-24 Process for obtaining derivatives 3-(1h-tetrazole-5-yl)-4h-pyrido(1,2-a)pyrimidin-4-ones
YU2330/82A YU44212B (en) 1977-05-25 1982-10-15 PROCESS FOR OBTAINING DERIVATIVES OF 3-(1H-TETRAZOL-5-YL)-(4H-PYRIDO)(1,2-a)-PYRIMIDINE-4-ONES

Family Applications After (1)

Application Number Title Priority Date Filing Date
YU2330/82A YU44212B (en) 1977-05-25 1982-10-15 PROCESS FOR OBTAINING DERIVATIVES OF 3-(1H-TETRAZOL-5-YL)-(4H-PYRIDO)(1,2-a)-PYRIMIDINE-4-ONES

Country Status (26)

Country Link
US (1) US4122274A (de)
JP (1) JPS6050197B2 (de)
AT (1) AT365187B (de)
AU (1) AU521211B2 (de)
BE (1) BE867295A (de)
CA (1) CA1098520A (de)
CH (1) CH642656A5 (de)
CY (1) CY1218A (de)
DE (1) DE2822544A1 (de)
DK (1) DK160279C (de)
FI (1) FI64594C (de)
FR (1) FR2401159A1 (de)
GB (1) GB1596476A (de)
GR (1) GR71887B (de)
HK (1) HK25884A (de)
IE (1) IE46849B1 (de)
IT (1) IT1105040B (de)
KE (1) KE3357A (de)
LU (1) LU79694A1 (de)
MY (1) MY8500305A (de)
NL (1) NL190702C (de)
NO (1) NO150361C (de)
SE (1) SE437830B (de)
SG (1) SG73383G (de)
YU (2) YU42163B (de)
ZA (1) ZA782816B (de)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU173438B (hu) * 1975-11-27 1979-05-28 Chinoin Gyogyszer Es Vegyeszet Sposob poluchenija novykh proizvodnykh 4-okso-1,6,7,8-/tetragidro-4h-pirido/1,2/pirimidina s zaderzhivajuhhejj vozgoranie aktivnot'ju i protivosvertivajuhhem effektom
US4495189A (en) * 1975-11-27 1985-01-22 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara R.T. Condensed pyrimidines
HU180439B (en) * 1977-12-29 1983-03-28 Chinoin Gyogyszer Es Vegyeszet Process for producing 9-amino-pyrido-square bracket-1,2-a-square bracket closed-pyrimidine derivatives
US4192944A (en) * 1978-04-03 1980-03-11 Bristol-Myers Company Optionally substituted 4-oxo-4H-pyrido[1,2-a]pyrimidine-3-N-(1H-tetrazol-4-yl)carboxamides and their use as antiallergy agents
US4491587A (en) * 1978-05-05 1985-01-01 Mead Johnson & Company Tetrazole derivatives
US4223031A (en) * 1978-05-05 1980-09-16 Mead Johnson & Company Azolopyrimidinones
US4282360A (en) * 1979-10-12 1981-08-04 Hoffmann-La Roche Inc. 7-Methylthio or methylsulfinyl-5-oxo-5H-thiazolo[2,3-b]quinazoline-2-carboxylic acid
US4419357A (en) * 1982-01-18 1983-12-06 The Dow Chemical Company 3-(1H-Tetrazol-5-yl)-4(3H)-quinazolinones
US4474953A (en) * 1982-09-09 1984-10-02 Riker Laboratories, Inc. Process and intermediates for the preparation of 3(1H-tetrazol-5-yl)-4H-pyrido[1,2-a]pyrimidin-4-ones
US4476130A (en) * 1982-09-09 1984-10-09 Riker Laboratories, Inc. 3-(1H-Tetrazol-5-yl)-4H-pyrimido[2,1-b]benzoxazol-4-one compounds exhibiting anti-allergic activity
US4507477A (en) * 1982-09-09 1985-03-26 Riker Laboratories, Inc. Process for tetrazolyl-pyrimidinone derivatives
US4457932A (en) * 1983-07-22 1984-07-03 Bristol-Myers Company Anti-ulcer agents
AU588917B2 (en) * 1985-09-25 1989-09-28 Shionogi & Co., Ltd. 9-(substituted thio)-4h-pryido(1,2-a) pyrimidin-4-one derivatives
JPS63183581A (ja) * 1985-10-03 1988-07-28 Tokyo Tanabe Co Ltd ピリド〔１，２−ａ〕ピリミジン誘導体、その製造法及びそれを有効成分とするアレルギ−疾患治療薬
JPS62242682A (ja) * 1986-04-16 1987-10-23 Tokyo Tanabe Co Ltd 新規なピリド［１，２―ａ］ピリミジン誘導体及びその製造法
JP2504788B2 (ja) * 1987-11-10 1996-06-05 東京田辺製薬株式会社 ９−メチル−３−（１Ｈ−テトラゾ―ル−５−イル）−４Ｈ−ピリド［１，２−ａ］ピリミジン−４−オンカリウム塩の水性製剤
WO1989006130A1 (en) * 1987-12-25 1989-07-13 Santen Pharmaceutical Co., Ltd. Antiallergic eye drop
CA2010336C (en) * 1989-02-27 1996-11-19 Atsunori Sano Process for producing pyrido[1,2-a]pyrimidine derivative
HU209793B (en) * 1990-09-25 1994-11-28 Chinoin Gyogyszer Es Vegyeszet Process for the production of pyrido[1,2-a]pyrimidine-derivatives and pharmaceutical compositions containing the same
WO1994003172A1 (en) 1992-07-30 1994-02-17 Tokyo Tanabe Company Limited Remedy for inflammatory intestinal diseases
US5527802A (en) * 1992-10-01 1996-06-18 Bristol-Myers Squibb Company New uses of 3-tetrazolo -5,6,7,8- substituted-pyrido (1,2-a) pyrimidin-4-ones
JPH0892093A (ja) * 1994-11-10 1996-04-09 Tokyo Tanabe Co Ltd ９−メチル−３−（１Ｈ−テトラゾール−５−イル）−４Ｈ−ピリド［１，２−ａ］ピリミジン−４−オンの水性製剤
JP4171303B2 (ja) * 2001-02-26 2008-10-22 田辺三菱製薬株式会社 腎疾患・腎不全の予防剤及び／又は治療剤
ITMI20011764A1 (it) 2001-08-10 2003-02-10 Dinamite Dipharma Spa Metodo per l'ottenimento del pemirolast ad elevata purezza
GB0316546D0 (en) * 2003-07-15 2003-08-20 Novartis Ag Process for the manufacture of organic compounds
CN101610765A (zh) * 2006-12-18 2009-12-23 卡多兹公司 用于治疗炎症的新组合物
CA2673214A1 (en) * 2006-12-20 2008-06-26 Cardoz Ab New combination for use in the treatment of inflammatory disorders
WO2009007675A2 (en) * 2007-07-11 2009-01-15 Cardoz Ab Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and a p2 gamma 12 antagonist
WO2009007673A2 (en) * 2007-07-11 2009-01-15 Cardoz Ab Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and a ppar gamma agonist
WO2009007679A2 (en) * 2007-07-11 2009-01-15 Cardoz Ab Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and a thromboxane a2 antagonist
AU2009235276A1 (en) * 2008-04-07 2009-10-15 Cardoz Ab New combination for use in the treatment of inflammatory disorders
SG176295A1 (en) 2009-06-16 2012-01-30 Cardoz Ab Crystalline form of pemirolast
USD661900S1 (en) 2010-02-22 2012-06-19 Bajer Design & Marketing, Inc. Collapsible structure
MX354074B (es) * 2012-02-10 2018-02-12 Ptc Therapeutics Inc Compuestos para tratar la atrofia muscular espinal.
CN104302181B (zh) 2012-03-01 2017-09-15 Ptc医疗公司 用于治疗脊髓性肌萎缩的化合物
EP2828247B1 (de) 2012-03-23 2019-01-16 PTC Therapeutics, Inc. 4h-chromen-4-onderivate zur behandlung von spinaler muskelatrophie
WO2015105657A1 (en) 2013-12-19 2015-07-16 Ptc Therapeutics, Inc. Methods for modulating the amount of rna transcripts
US20160243122A1 (en) 2014-10-23 2016-08-25 Rspr Pharma Ab Use of pemirolast in the treatment of acute asthma
WO2016102941A1 (en) 2014-12-22 2016-06-30 Rspr Pharma Ab New combination of pemirolast and montelukast
WO2016184832A1 (en) * 2015-05-20 2016-11-24 F. Hoffmann-La Roche Ag Compounds for treating spinal muscular atrophy
EP3310169B1 (de) 2015-05-30 2023-05-17 PTC Therapeutics, Inc. Verfahren zur modulation von rna-spleissen
GB201518831D0 (en) 2015-10-23 2015-12-09 Rspr Pharma Ab New use
CA3119019C (en) 2015-12-10 2024-06-11 Ptc Therapeutics, Inc. Compounds and methods for treating huntington's disease
GB201601138D0 (en) * 2016-01-21 2016-03-09 Rspr Pharma Ab New use
EP3544435A4 (de) 2016-11-28 2020-11-04 PTC Therapeutics, Inc. Verfahren zur modulation von rna-splicing
SG11201911615WA (en) 2017-06-05 2020-01-30 Ptc Therapeutics Inc Compounds for treating huntington's disease
KR20200017476A (ko) 2017-06-14 2020-02-18 피티씨 테라퓨틱스, 인크. Rna 스플라이싱의 변경 방법
US11395822B2 (en) 2017-06-28 2022-07-26 Ptc Therapeutics, Inc. Methods for treating Huntington's disease
BR112019027717A2 (pt) 2017-06-28 2020-07-28 Ptc Therapeutics, Inc. métodos para tratar a doença de huntington
US12103926B2 (en) 2018-03-27 2024-10-01 Ptc Therapeutics, Inc. Compounds for treating huntington's disease
LT3814357T (lt) 2018-06-27 2024-06-25 Ptc Therapeutics, Inc. Heterocikliniai ir heteroarilų junginiai, skirti hantingtono ligos gydymui
US11685746B2 (en) 2018-06-27 2023-06-27 Ptc Therapeutics, Inc. Heteroaryl compounds for treating Huntington's disease

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3072485A (en) * 1960-08-24 1963-01-08 Eastman Kodak Co Optically sensitized azido polymers for photomechanical resist compositions
AT294107B (de) * 1966-11-02 1971-11-10 Chinoin Gyogyszer Es Vegyeszet Verfahren zur Herstellung von neuen Homopyrimidazol-Derivaten sowie von deren Salzen
US3960847A (en) * 1972-04-17 1976-06-01 E. R. Squibb & Sons, Inc. 9-Substituted-4-oxopyrido(1,2-α)pyrimidine-3-carboxylic acids and derivatives thereof
US3929787A (en) * 1974-04-22 1975-12-30 Squibb & Sons Inc 6,7,8,9-Tetrahydro-pyrido(1,2-a)pyrimidin-4-ones
US3960863A (en) * 1974-06-25 1976-06-01 Sankyo Company Limited Pyrido[1,2-a]pyrimidinone derivatives
US4017625A (en) * 1975-08-01 1977-04-12 Pfizer Inc. Anti-allergic N-(5-tetrazolyl)-1-oxo-1H-6-alkoxypyrimido-[1,2-a]quinoline-2-carboxamides and intermediates therefor
US4012387A (en) * 1975-09-18 1977-03-15 Warner-Lambert Company Benzo-[g]pyrido[2,1-b]quinazolinones

Also Published As

Publication number Publication date
IT7849523A0 (it) 1978-05-24
NO150361B (no) 1984-06-25
NL190702C (nl) 1994-07-01
LU79694A1 (fr) 1979-02-02
SE7805954L (sv) 1978-11-26
NL190702B (nl) 1994-02-01
US4122274A (en) 1978-10-24
FR2401159A1 (fr) 1979-03-23
CA1098520A (en) 1981-03-31
DE2822544C2 (de) 1988-10-27
NO150361C (no) 1984-10-03
FI64594B (fi) 1983-08-31
DE2822544A1 (de) 1978-12-07
AU3631978A (en) 1979-11-29
CY1218A (en) 1984-04-06
HK25884A (en) 1984-03-30
JPS6050197B2 (ja) 1985-11-07
FI64594C (fi) 1983-12-12
IE781036L (en) 1978-11-25
YU123678A (en) 1983-02-28
DK160279B (da) 1991-02-18
FI781614A (fi) 1978-11-26
BE867295A (fr) 1978-11-20
FR2401159B1 (de) 1983-05-20
YU44212B (en) 1990-04-30
DK228878A (da) 1978-11-26
SG73383G (en) 1984-08-03
IT1105040B (it) 1985-10-28
YU233082A (en) 1988-08-31
CH642656A5 (de) 1984-04-30
ATA373278A (de) 1981-05-15
ZA782816B (en) 1979-05-30
JPS5436294A (en) 1979-03-16
MY8500305A (en) 1985-12-31
KE3357A (en) 1984-02-03
IE46849B1 (en) 1983-10-05
NO781786L (no) 1978-11-28
AT365187B (de) 1981-12-28
GB1596476A (en) 1981-08-26
DK160279C (da) 1991-07-22
AU521211B2 (en) 1982-03-25
SE437830B (sv) 1985-03-18
GR71887B (de) 1983-08-04
NL7805534A (nl) 1978-11-28

Similar Documents

Publication Publication Date Title
YU42163B (en) Process for obtaining derivatives 3-(1h-tetrazole-5-yl)-4h-pyrido(1,2-a)pyrimidin-4-ones
PH16530A (en) Novel 3-(1-piperidinyl)4h-pyrido(1,2-a-)pyrimidine-4-one derivatives
YU279582A (en) Process for obtaining pyrido(1,2-a)pyrimidine derivatives
YU196678A (en) Process for preparing (1,2-a)pyrimidine derivatives
YU172177A (en) Process for obtaining 5-aroyl-1,2-dihydro-3h-pyrrolo (1,2-a) pyrrol-1-carboxylic derivatives
JPS56150091A (en) 3-(1-piperidinylalkyl)-4h-pyrido(1,2-a)pyrimidine- 4-one derivative and its manufacture
AU516695B2 (en) Heterocyclic substituted imidazo (1, 2-a)pyridines
YU44663B (en) Process for obtaining 4-substituted imidazo /1,2a/ hynoxaline
PH13756A (en) Trans-5-aryl-2,3,4,4a,5,9b-hexahydro-in pyrido(4,3-b)indoles
GB2050353B (en) Substituted pyrido(1,2-a) pyrimidines
PT67820A (en) Process for preparing novel pyrido(2,1-b)-quinazoline derivatives
GR65275B (en) Method for the preparation of 2,3-polymethyleno-4-oxo-4h-pyrido(1,2-a)pyrimidins
YU296378A (en) Process for preparing pyrido(1,2-a)pyrimidine derivatives
SE7801489L (sv) Forfarande for framstellning av imidazo (1,5-b) pyridaziner
PT71177B (en) Process for preparing 3-substituted imidazo (1,2-a) piridines
HU174901B (hu) Sposob poluchenija novykh proizvodnykh pirido/1,2-a/pirimidina
AU519315B2 (en) TRIAZOLO 4, 5-b QUINOLINE DERIVATIVES
ZA785728B (en) Novel substituted imidazo(1,2-a)pyridine compounds as anthelmintics
YU122280A (en) Process for obtaining 9-hydrazono-6,7,8,9-tetrahydro-4h-pyrido-(1,2-a)-pyrimidin-4-one derivatives
YU115380A (en) Process for obtaining new pyrido(2,3-e)-as-triazine derivatives
HU175301B (hu) Sposob poluchenija 5-zameshchjonnykh proizvodnykh 1,2-digidro-3h-pirrolo/1,2-a/pirrol-1-karbonovoj kisloty